CIK 0001877184 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
KESTRA MEDICAL TECHNOLOGIES, LTD.
Sign in to watch- Ticker
- KMTS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 30
- Incorporated
- Bermuda
- Entity type
- operating
- Phone
- (425) 279-8002
- Business address
- 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND, WA, 98033
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,586,347
- in 12 filings, $6.9M under 10b5-1 plans
Net −$7,586,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | Moran Timothy P. Chief Business Officer | Sale | −3,192 | $29.56 | $94K | 63,153 |
| 2026-10-29 | Mahboob Vaseem Chief Financial Officer | Option exercise 10b5-1 | +4,788 | $17.00 | $81K | 65,397 |
| 2026-10-29 | Mahboob Vaseem Chief Financial Officer | Sale 10b5-1 | −4,788 | $30.60 | $147K | 60,609 |
| 2026-10-29 | Mahboob Vaseem Chief Financial Officer | Option exercise · Options 10b5-1 | −4,788 | 79,500 | ||
| 2026-10-28 | Mahboob Vaseem Chief Financial Officer | Option exercise 10b5-1 | +39,903 | $17.00 | $678K | 100,512 |
| 2026-10-28 | Mahboob Vaseem Chief Financial Officer | Sale 10b5-1 | −39,903 | $30.48 | $1.2M | 60,609 |
| 2026-10-28 | Mahboob Vaseem Chief Financial Officer | Option exercise · Options 10b5-1 | −39,903 | 84,288 | ||
| 2026-10-27 | Mahboob Vaseem Chief Financial Officer | Option exercise 10b5-1 | +34,809 | $17.00 | $592K | 95,418 |
| 2026-10-27 | Mahboob Vaseem Chief Financial Officer | Sale 10b5-1 | −34,809 | $30.04 | $1.0M | 60,609 |
| 2026-10-27 | Mahboob Vaseem Chief Financial Officer | Option exercise · Options 10b5-1 | −34,809 | 124,191 | ||
| 2026-10-27 | Umberger Traci S See Remarks | Option exercise 10b5-1 | +30,000 | $17.00 | $510K | 225,825 |
| 2026-10-27 | Umberger Traci S See Remarks | Sale 10b5-1 | −30,000 | $30.03 | $901K | 195,825 |
| 2026-10-27 | Umberger Traci S See Remarks | Option exercise · Options 10b5-1 | −30,000 | 411,000 | ||
| 2026-10-21 | Umberger Traci S See Remarks | Option exercise 10b5-1 | +100,000 | $17.00 | $1.7M | 295,825 |
| 2026-10-21 | Umberger Traci S See Remarks | Sale 10b5-1 | −96,404 | $27.15 | $2.6M | 199,421 |
| 2026-10-21 | Umberger Traci S See Remarks | Sale 10b5-1 | −3,596 | $28.09 | $101K | 195,825 |
| 2026-10-21 | Umberger Traci S See Remarks | Option exercise · Options 10b5-1 | −100,000 | 441,000 | ||
| 2026-10-20 | Webster Brian Daniel See Remarks | Sale 10b5-1 | −13,316 | $29.52 | $393K | 446,899 |
| 2026-10-20 | Webster Brian Daniel See Remarks | Sale 10b5-1 | −1,684 | $29.89 | $50K | 445,215 |
| 2026-09-30 | COHEN RAYMOND W Director | Sale | −3,330 | $29.28 | $98K | 54,790 |
Page 1 of 5 · 98 trades